According to Beam Therapeutics 's latest financial reports the company's current EPS (TTM) is -$6.42. In 2022 the company made an earnings per share (EPS) of -$5.88 an increase over its 2021 EPS that were of -$8.47.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.10 | 3.68% |
2022 | -$5.88 | -30.59% |
2021 | -$8.47 | 38.69% |
2020 | -$6.11 | 79.35% |
2019 | -$3.40 |